Analysis: US-UK trade deal could force NHS to divert billions to medicines, critics warn
By
Lucy Hough, Aditya Chakrabortty, Leonore Schick, Sam Gruet, Ryan Ramgobin
Summary
Analysis claims the US-UK trade deal agreed in December will force the NHS to divert billions from essential services to pay for new medicines, potentially causing over 200,000 excess deaths. The Labour government defends the deal as beneficial for British drug exports and patient access, while critics accuse them of bowing to pressure from Donald Trump. The piece is a short interview/opinion segment between Lucy Hough and columnist Aditya Chakrabortty.
Source

Key quotes
· 2 pulledThe NHS will divert billions of pounds from essential services to pay for new medicines, under the terms of the US-UK trade deal agreed in December, which could lead to more than 200,000 excess deaths, analysis has found.
Ministers have defended the deal as a way of helping British drug exports avoid US tariffs and giving patients access to vital medication, but critics accuse the Labour party of caving into pressure from Donald Trump.
You might also wanna read
Analysis: UK-US pharmaceuticals trade deal could divert NHS funds and harm public health
This article argues that the UK-US pharmaceuticals trade deal, announced on 1 December 2025, will harm public health by diverting billions o
Analysis: UK-US pharmaceuticals trade deal could divert NHS funds and harm public health
This article argues that the UK-US pharmaceuticals trade deal, announced on 1 December 2025, will harm public health by diverting billions o
Activists oppose NHS England's use of Palantir software for health records
The article is a strongly opinionated piece opposing NHS England's decision to roll out Palantir's software for managing health records. It
Activists oppose NHS England's use of Palantir software for health records
The article is a strongly opinionated piece opposing NHS England's decision to roll out Palantir's software for managing health records. It
U.S. restrictions on Chinese biotech could harm patients, argues editorial
The article argues against U.S. efforts to restrict collaboration with China's biotechnology industry, framing it as an extension of the tec
U.S. restrictions on Chinese biotech could harm patients, argues editorial
The article argues against U.S. efforts to restrict collaboration with China's biotechnology industry, framing it as an extension of the tec
EU Parliament Delays US Trade Deal Ratification After Trump's Greenland Tariff Threats
The European Parliament has frozen ratification of a key trade deal with the United States in response to President Donald Trump's tariff th

BFI Lobbied UK Government to Exclude Film and TV Industries from Trump Trade Deal
The British Film Institute (BFI) lobbied the UK government in May 2025 to exclude the country's film and TV industries from any trade deal w

NYC Public Hospitals End Palantir Contract Amid UK Controversy Over Government Deals
New York City's public hospital system is ending its contract with Palantir, the controversial AI and data analytics firm, as the contract e

Comments
Sign in to join the conversation.
No comments yet. Be the first.